Table 1 Population characteristics at baseline
MDR-TB treatment outcomes | |||
|---|---|---|---|
Total (n = 165) | Cured (n = 133) | Dead (n = 32) | |
Age at baseline | 33.3 (11.6) | 32.2 (10.5) | 37.5 (14.7) |
Sex (male) | 111 (67.3) | 97 (72.9) | 14 (43.8) |
Residence (urban) | 122 (73.9) | 37 (27.8) | 6 (18.8) |
BMI | 17.5 (2.7) | 17.8 (2.6) | 16. 0 (2.7) |
Initial sputum smear (positive) | 145 (87.9) | 120 (90.2) | 25 (78.1) |
Initial sputum culture (positive) | 137 (83.0) | 113 (88.9) | 24 (85.7) |
HIV status (positive) | 42 (25.6) | 27 (20.5) | 15 (46.9) |
Lung cavities on X-ray (yes) | 13 (9.1) | 9 (7.7) | 4 (15.4) |
History of TB treatment (previously treated) | 134 (81.2) | 114 (85.7) | 20 (62.5) |
Treatment adherence (yes) | 144 (87.3) | 128 (96.2) | 16 (50.0) |
Depression (yes) | 8 (4.9) | 2 (1.50) | 6 (18.8) |
Chest pain (yes) | 73 (44.2) | 54 (40.6) | 19 (59.4) |
Cough (yes) | 156 (94.6) | 127 (95.5) | 29 (90.6) |
Dyspnea (yes) | 52 (31.5) | 34 (25.6) | 18 (56.3) |
Nausea (yes) | 13 (7.9) | 7 (5.3) | 6 (18.8) |
Vomiting (yes) | 17 (10.3) | 10 (7.5) | 7 (21.9) |
Hemoglobin count | 10.7 (2.2) | 10.8 (2.1) | 10.0 (2.6) |
Platelet count | 388.0 (159.9) | 396.1 (152.4) | 353.8 (187.1) |
Lymphocyte count | 1.9 (1.4) | 1.8 (0.9) | 2.0 (2.6) |
Neutrophil count | 5.0 (2.6) | 5.0 (2.6) | 5.5 (2.7) |
Creatinine | 77.7 (19.6) | 76.8 (19.5) | 81.3 (19.7) |
SGOT | 29.6 (5.4) | 29.2 (3.8) | 31.2 (9.3) |
SGPT | 32.2 (5.0) | 32.2 (4.2) | 32.3 (7.6) |